Corebridge Financial, Inc. CRBG 深 沪
已收盘 05-15 16:00:00 美东时间
27.56
-0.100
-0.36%
华盛通- 最 高27.78
- 今 开27.54
- 成交量 694.73万股
- 最 低 27.15
- 昨 收 27.66
- 总市值 125.87亿
- 52周最高 35.84
- 市盈率 静 --
- 换手率 1.52%
- 52周最低 22.07
- 委 比 4.95%
- 总股本 4.57亿
- 历史最高 35.84
- 量 比 0.97
- 振 幅 2.28%
- 历史最低 9.41
- 每 手 1
- 风险率 3.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Mizuho Maintains Outperform on Corebridge Financial, Raises Price Target to $35
Mizuho analyst Yaron Kinar maintains Corebridge Financial (NYSE:CRBG) with a Outperform and raises the price target from $31 to $35.
05-07 20:20
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
American International Group To Sell 25M Shares Of Corebridge Financial For ~$710M, Exiting Stake
American International Group, Inc. (NYSE:AIG) today announced that it has agreed to sell approximately 25 million shares of common stock of Corebridge Financial, Inc. (NYSE:CRBG), representing its remaining stake in the
05-06 05:56
Corebridge Financial shares are trading higher. The company reported Q1 financial results.
Corebridge Financial shares are trading higher. The company reported Q1 financi...
05-05 22:25
Corebridge Financial Q1 Adj. EPS $1.05, Inline, Sales $4.085B Miss $5.061B Estimate
Corebridge Financial (NYSE:CRBG) reported quarterly earnings of $1.05 per share which met the analyst consensus estimate. This is a 9.48 percent decrease over earnings of $1.16 per share from the same period last year.
05-05 04:29
Earnings Scheduled For May 4, 2026
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
美股大行评级 | 达美乐比萨惨遭10家大行下调目标价；铿腾电子、艾克尔科技、Relay 、辛普森配件制造、TFI International等获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Intellia Therapeutics"买入"评级，目标价从48美元升至58美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从7美元升至8美元
04-29 10:28
UBS Maintains Neutral on Corebridge Financial, Lowers Price Target to $29
UBS analyst Michael Ward maintains Corebridge Financial (NYSE:CRBG) with a Neutral and lowers the price target from $33 to $29.
04-28 22:20
